NEW YORK, Aug 19 (Reuters) - A federal judge has blocked 10 companies from selling generic versions of Eli Lilly and Co's Strattera attention deficit disorder drug while Lilly appeals a ruling that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback